CPSS

Over the past six months, CPSS closed an $80.0 million securitization of residual interests in August 2026. In Q2 2026, the company reported a 30% increase in net income to $6.2 million, a 35% rise in diluted EPS to $0.27, 10.6% revenue growth to $121.4 million, and a 75% surge in new contract purchases to $757.7 million, with the total portfolio exceeding $4 billion. Q1 2026 results included revenues of $112.3 million, net income of $5.5 million, and diluted EPS of $0.24, with the portfolio reaching a record $3.942 billion and new contract purchases up 18% year-over-year. Delinquencies decreased to 11.58%, while annualized net charge-offs increased to 8.57%. In April 2026, CPSS amended its revolving credit agreement with Capital One, increasing capacity from $167.5 million to $390 million, and announced a $514.07 million senior/subordinate securitization. Insider trading included VP Noel Jackson selling 7,500 shares and Charles Bradley, Jr. selling 125,000 shares in August and September 2026, with insiders collectively making three sales totaling $1.2 million over 90 days. As of September 18, 2026, the stock was downgraded to a 'Strong Sell Candidate' by StockInvest.us despite a 6.02% rise over two weeks, while MarketBeat provided a consensus 'Hold' rating. The stock price on September 22, 2026, was $9.34, with a 52-week high of $10.49 and a 52-week low of $7.30.